OROTECAN

Welcome to the Brand page for “OROTECAN”, which is offered here for Pharmaceutical products in the nature of antineoplastic topoisomerase i inhibitors used for the prevention and treatment of cancer;.

Its status is currently believed to be active. Its class is unavailable. “OROTECAN” is believed to be currently owned by “Edison Oncology Holding Corp.”


Owner:
EDISON ONCOLOGY HOLDING CORP.
Owner Details
Description:
Pharmaceutical products in the nature of antineoplastic topoisomerase I inhibitors used for the prevention and treatment of cancer;
Categories: PHARMACEUTICAL PRODUCTS NATURE